相关实验视频

Updated: Jun 27, 2026

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Published on: April 4, 2011

自组装纳米粒子血素流感疫苗诱导高抗体反应

Hongying Ren¹, Bin Zhang¹, Xinwei Zhang²

¹Department of Microorganism Engineering, Beijing Institute of Biotechnology, Beijing 100071, China.

International journal of molecular sciences

|July 13, 2024

概括

一种使用HA5血凝素和支架蛋白的新型纳米粒子流感疫苗证明了提高免疫性. 这种H5型流感疫苗设计为加强禽类和公共卫生安全提供了一个有希望的战略.

科学领域:

病毒学病毒学
免疫学免疫学免疫学
生物技术是生物技术.

背景情况:

高致病性H5型流感病毒对家禽,牲畜和公共健康构成重大风险.
血凝素 (HA) 是中和流感抗体的关键目标.
开发更多的免疫性流感疫苗对于有效的疾病控制至关重要.

研究的目的:

设计和评估一种新的纳米粒子流感疫苗,以增强免疫性.
研究与脚手架蛋白结合的H5血素的自我组装和免疫性.

主要方法:

通过使用baculovirus表达系统,设计了HA5-I53_dn5B/Y98F三元体.
使用 prokaryotic 表达系统产生了 I53_dn5A.
自组装HA5-I53_dn5B/Y98F和I53_dn5A成45nm球形纳米粒子 (HA5-I53_dn5) 在体外.

主要成果:

这两种HA5-I53_dn5B/Y98F和HA5-I53_dn5纳米粒子都成功诱导了H5特异性抗体.
与单独的HA5-I53_dn5B/Y98F相比,HA5-I53_dn5纳米粒子疫苗表现出更好的免疫性.
纳米颗粒配方引起的IgG抗体标位与辅助剂相比较.

结论:

三元化HA5-I53_dn5B和HA5-I53_dn5纳米颗粒可以有效地使用baculovirus表达产生.
开发的纳米粒子疫苗显示出作为对H5流感的安全和有效策略的潜力.
这种方法为未来的新型流感疫苗开发提供了宝贵的参考.

关键词:

流感病毒H5亚型流感病毒H5亚型细菌病毒表达系统的表达系统血凝氨酸是什么血凝氨酸纳米颗粒疫苗的使用方法

更多相关视频

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

相关概念视频

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Influenza

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...

Inhibitors Of Virion Release

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...